The last couple of years have taught the public terms such as rate of contagion, exponential growth, and percentage of effectiveness. It...

As a response to the current global pandemic, many countries have awoken to the fragility of domestic supply chains for drugs. For many,...

There is one thing both regulatory bodies and pharmaceutical industry leaders agree on: the supply chain of generic drugs is not 100%...

The keys to staying competitive in the pharmaceutical supply chain have changed since the appearance of COVID-19. Here at The J. Molner...